Abstract: Wingless-type protein (Wnt) is a family of 19 secreted glycoproteins that function as signaling transducers for cell-cell interaction, cell growth and differentiation. Wnt-1, a highly transforming member, has been implicated in tumorigenesis. The aim of this study was to elucidate the role of this cell signaling molecule in the development and progression of primary ameloblastoma and their recurrent tumors. Wnt-1 expression patterns were examined immunohistochemically in 22 primary and 14 recurrent ameloblastomas. These collectively consisted of the following subtypes: conventional (CA) (n=22), desmoplastic (DA) (n=2) and unicystic (UA) (n=12) ameloblastoma. Results demonstrated that CA (n=20/22; 90.9%), DA (n =2/2; 100%) and UA (11/12; 91.7%) showed high Wnt-1 expression percentages. Strong staining intensity for Wnt-1 was observed more frequently in primary CA (n =10/13; 76.9%) than in their recurrent counterparts (n= 2/9; 22.2%) (p<0.05). Conversely, in UA, recurrent tumors (n=3/5; 60.0%) tend to stain strongly for Wnt-1 more frequently than their primary lesions (n=3/7; 42.9%) (p>0.05). Keratinizing cells in areas of squamous metaplasia also expressed Wnt-1 more intensely compared to their surrounding polyhedral stellate reticulum-like cells. Tumor islands containing granular cells were also Wnt-1 positive. Present findings confirmed that the Wnt signaling pathway is activated in ameloblastoma. Strong Wnt-1 expression in primary conventional and recurrent unicystic ameloblastoma suggests that Wnt-1 plays a more critical role in these subtypes. Positive expression of Wnt-1 in keratinizing ameloblastomatous tumor epithelium and granular cells complies with the anti-apoptotic properties of Wnt-1. Negative reactivity for Wnt-1 in 3 cases of ameloblastoma suggests that the development and progression of ameloblastoma may occur independent of this cell signaling molecule.
Introduction
Ameloblastoma is a histological benign, but locally aggressive tumor arising from the odontogenic ectoderm and its derivatives.
According to the World Health Organization, ameloblastoma is classified into four clinicopathological subtypes: unicystic, conventional (solid/multicystic), peripheral and malignant 1) .
Histologically, there are two basic growth patterns, follicular and plexiform.
Wingless-type protein-1 (Wnt-1), belongs to a large family of 19 secreted glycoproteins that act as signaling transducers involved in cell proliferation and development 2) . Wnt-1 proteins signal via the Wnt/canonical pathway. There is evidence that this signaling pathway plays a critical role in tumorigenesis [2] [3] . Previous studies have shown Wnt-1 overexpression in human cancers including basal cell carcinoma 4) , oral squamous cell carcinoma 5) , non-small cell lung cancer 6) and mammary cancer 7) .
The development and progression of ameloblastoma is a complex and ill-understand process. Many genes involved in tooth development too play critical roles in the tumorigenesis of ameloblastoma [8] [9] [10] [11] [12] [13] [14] . The canonical Wnt signaling molecules play an essential role during tooth development [15] [16] . Thus far Wnts-1 17) , -3, -4, -5a, -6, -7b and 10b 15) expressions during tooth development from the earliest formation of epithelial thickenings to early bell stage have been clarified. Some of these cell signaling molecules namely Wnt-1 17) , Wnt-2, Wnt-5a 18) , beta-catenin, APC 19) , AXIN1 and AXIN2 20) have been examined in ameloblastoma, The aim of this study was to determine the immunolocalization of Wnt-1 in ameloblastomas in terms of its distribution and staining intensity in primary conventional and unicystic ameloblastomas and their recurrent tumors, and to speculate on the relevance of these findings in relation to the development and progression of this neoplasm.
Materials and methods

Tissue samples
The tissue samples in this study were from the surgical 
Staining intensity
The tumors were analyzed subjectively according to the 
Statistical analysis
Chi square test was performed to compare the expression level of Wnt-1 with the clinicopathological subtypes of ameloblastoma.
Level of significance was set at p<0.05.
Results
Clinical findings
The clinical characteristics of the cases in the study sample are detailed in Table 1 . There were 23 (63.9%) male and 13 (36.1%) female patients with an overall mean age of 27.4 years (age range: 11-57 years). Their racial composition was 50.0%
Chinese, 33.3% Malays, 11.1% Indians and 5.6% other races.
Thirty-three cases (91.7%) were from the mandible and the remaining 3 (8.3%) cases were from the maxilla.
Immunohistochemical findings
The immunohistochemical results and grades of staining intensity are summarized in Table 2 and illustrated in Figs. 1-3.
Wnt-1 expression was detected in 33 (91.7%) out of 36 cases of ameloblastoma. Their localization patterns according to the subtypes are detailed below.
Conventional ameloblastoma (n=22)
Ten cases of plexiform, 8 follicular and 4 mixed plexiformfollicular ameloblastomas were examined (Table 2 and (Fig. 3 , E-F).
Desmoplastic ameloblastoma (n=2)
Both cases stained positive for Wnt-1 (Table 2 and Fig. 3, D) .
Wnt-1 activity was variably localized in the cell membrane and cytoplasm of both peripheral and central tumor epithelial cells.
Unicystic ameloblastoma (n=12)
Five cases each of simple and mural unicystic ameloblastoma, and 2 cases of plexiform unicystic ameloblastoma were examined (Table 2 mammary tumor virus in mouse mammary carcinoma 21) . It is classified as a highly transforming Wnt by virtue of its high transforming ability to promote tumor progression. Mutations of Wnt genes may cause inappropriate activation of the Wnt signaling pathways leading to tumor development and progression [22] [23] .
Strong genetic evidence from studies in mice, Drosophila and
Xenopus suggests a critical role of Wnt-1 in induced tumorigenesis.
In particular, Wnt-1 has been implicated in the abnormal proliferation of human tissues. Aberrant levels of Wnt-1 have been detected in a variety of human tumors and cancers including oral squamous cell carcinoma 5) , basal cell carcinoma 4) , non small cell lung cancer 6) and mammary cancer 7) .
Cell signaling molecules have also been examined in ameloblastoma. Wnt-1 protein has been detected in the epithelial tumor cells of intraosseous ameloblastoma of follicular, acanthomatous, desmoplastic and plexiform subtypes 17) . Strong expression of beta-catenin and Wnt-5a and lack of reactivity for Wnt-2 was demonstrated in granular cell ameloblastoma 18) .
Activation of Wnt signaling pathway through demonstration of nuclear beta-catenin accumulations and mutations of AXIN1 and AXIN2 have also been documented 20) .
The purpose of this study was to characterize primary and recurrent ameloblastoma based on variations in protein expression patterns derived from immunohistochemical analysis of Wnt-1.
To fulfill this purpose, a total of 22 primary and 14 recurrent ameloblastomas were examined with regards to the immunolocalization and intensity of reactivity of Wnt-1 in the various neoplastic cellular components of ameloblastoma. Our results showed that Wnt-1 expression was upregulated in 33 (91.7%) out of 36 cases of ameloblastoma. This score is considerably higher than a previous study 17) where 19 (65.5%) out of 29 ameloblastoma tumor samples reportedly expressed Wnt-1. The disparity in findings 17) may be due to two main reasons.
Firstly, differences in the spectrum of ameloblastoma subtypes analyzed between the earlier study 17) and the current series may account for the difference in the percentages of Wnt-1 positive tumors observed (variation in Wnt-1 expression profile and ameloblastoma subtypes will be discussed later). In the earlier study 17) there were 13 follicular, 9 plexiform, 3 acanthomatous and 4 desmoplastic ameloblastoma whereas the present series plexiform) ameloblastomas. Secondly, it was not known whether the ameloblastoma tumor sample evaluated 17) represented primary or recurrent tumors. This factor may influence to a certain extent the expression profile for Wnt-1 (to be discussed later). The Wnt signaling mechanism can be activated through 3 distinct pathways namely the canonical/β-catenin, planar polarity and the Wnt/ Ca . This is because
Wnt interaction with its Freezle receptor activates this mechanism via the canonical/b-catenin pathway leading to the accumulation of â-catenin initially in the cytoplasm and subsequently translocated to the nucleus 24) .
In the present series, the loss of expression for Wnt-1 in the remaining 3 cases (2 follicular and 1 simple unicystic ameloblastomas) suggests that tumorigenesis in the ameloblastoma may occur independent of Wnt-1 activity. Wnt-1-independent tumorigenesis has also been reported in some cases of colorectal cancers 25) .
It is well-known that ameloblastoma is a benign but locallyinvasive odontogenic epithelial neoplasm which has a tendency to recur even after many years of apparent cure 1) . It is also known that the conventional ameloblastoma is a biologically more aggressive tumor in terms of its local behavior and potential for recurrence than the unicystic variant 1) . Therefore it seems prudent to determine how useful is the Wnt-1 protein molecule as a marker of tumor behavior by evaluating whether any differences exist in the expression pattern for Wnt-1 between conventional and unicystic ameloblastoma. In the present study, 10 (76.9%) cases of primary conventional ameloblastoma demonstrated strong Wnt-1 immunoreactivity, and this may denote that this ameloblastoma subtype often tends towards an increased cell proliferation 17) . This finding concurs well with the highly transforming ability of Wnt- A disparity in the intensity of . Similarly keratinizing and granular cells within the central layer were also viewed as pro-apoptotic sites 27) . In the current study, we observed that there was a tendency for granular cells 
